SG11201502646RA - Methods for predicting and monitoring mucosal healing - Google Patents

Methods for predicting and monitoring mucosal healing

Info

Publication number
SG11201502646RA
SG11201502646RA SG11201502646RA SG11201502646RA SG11201502646RA SG 11201502646R A SG11201502646R A SG 11201502646RA SG 11201502646R A SG11201502646R A SG 11201502646RA SG 11201502646R A SG11201502646R A SG 11201502646RA SG 11201502646R A SG11201502646R A SG 11201502646RA
Authority
SG
Singapore
Prior art keywords
predicting
methods
mucosal healing
monitoring mucosal
monitoring
Prior art date
Application number
SG11201502646RA
Other languages
English (en)
Inventor
Sharat Singh
Xinjun Liu
Scott Hauenstein
Richard Kirkland
Katherine Drake
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of SG11201502646RA publication Critical patent/SG11201502646RA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/065Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201502646RA 2012-10-05 2013-10-02 Methods for predicting and monitoring mucosal healing SG11201502646RA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261710491P 2012-10-05 2012-10-05
US201361824959P 2013-05-17 2013-05-17
PCT/IB2013/059077 WO2014054013A1 (fr) 2012-10-05 2013-10-02 Méthodes de prédiction et de surveillance de la cicatrisation des muqueuses

Publications (1)

Publication Number Publication Date
SG11201502646RA true SG11201502646RA (en) 2015-05-28

Family

ID=49447587

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502646RA SG11201502646RA (en) 2012-10-05 2013-10-02 Methods for predicting and monitoring mucosal healing

Country Status (11)

Country Link
US (1) US20150355195A1 (fr)
EP (3) EP2904405B1 (fr)
JP (1) JP2015532425A (fr)
CN (1) CN104838270A (fr)
AU (2) AU2013326070A1 (fr)
CA (1) CA2887035A1 (fr)
ES (2) ES2771127T3 (fr)
HK (1) HK1213051A1 (fr)
MX (1) MX358730B (fr)
SG (1) SG11201502646RA (fr)
WO (1) WO2014054013A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012154987A1 (fr) 2011-05-10 2012-11-15 Nestec Sa Méthodes de profilage de l'activité d'une maladie pour une prise en charge thérapeutique personnalisée
MX2017004816A (es) * 2014-10-20 2017-08-02 Nestec Sa Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa.
US20170258820A1 (en) 2014-10-29 2017-09-14 Glycom A/S Synthetic composition and method for promoting mucosal healing
GB201501612D0 (en) * 2015-01-30 2015-03-18 Univ Birmingham Assay
GB201611738D0 (en) 2016-07-05 2016-08-17 Cambridge Entpr Ltd Biomarkers for inflammatory bowel disease
KR20200009095A (ko) 2017-05-31 2020-01-29 프로메테우스 바이오사이언시즈, 인크. 크론병 환자에서 점막 치유를 평가하는 방법
CN110646620A (zh) * 2019-09-29 2020-01-03 湖北新纵科病毒疾病工程技术有限公司 一种同时检测四项炎症标志物的方法及其试剂盒
CN111477325A (zh) * 2020-04-09 2020-07-31 赣南师范大学 基于粒子群优化算法对引发肠道溃疡疾病进行鉴别的方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0615129B1 (fr) 1993-03-10 2000-05-31 Cedars-Sinai Medical Center Procédé pour détecter sélectivement des anticorps périnucléaires cytoplasmiques, anti-neutrophiles de colite ulcéreuse ou de cholangite primaire sclérosante
US5830675A (en) 1993-03-10 1998-11-03 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
US6218129B1 (en) 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
US6406862B1 (en) 1998-10-06 2002-06-18 The United States Of America As Represented By The Secretary Of The Army Dip-stick assay for C-reactive protein
FR2802536B1 (fr) 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
US6838250B2 (en) 2000-03-31 2005-01-04 Ortho-Clinical Diagnostics, Inc. Immunoassay for C-reactive protein
WO2001081404A2 (fr) * 2000-04-20 2001-11-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services VECTEUR PLASMIDIQUE INDUCTIBLE CODANT TGF-ss, ET SES UTILISATIONS
US7138237B1 (en) 2000-05-19 2006-11-21 Cedars-Sinai Medical Center Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
CA2860702C (fr) 2001-12-17 2019-02-26 Corixa Corporation Compositions et procedes applicables a la therapie et au diagnostic pour la maladie intestinale inflammatoire
US20040197304A1 (en) * 2003-04-01 2004-10-07 The Procter & Gamble Company And Alimentary Health, Ltd. Methods of determining efficacy of treatments of inflammatory diseases of the bowel
EP1687447A4 (fr) 2003-11-03 2008-04-02 Univ Duke Procedes pour identifier les individus presentant un risque perioperatoire de saignements, de dysfonction renale ou d'ictus
WO2006012472A1 (fr) 2004-07-21 2006-02-02 Qualyst, Inc. Appareils, kits et procedes pour l'evaluation d'interactions de liaison, la detection et la quantification de molecules de liaison, et la preparation d'echantillons
US7868139B2 (en) 2006-01-24 2011-01-11 Uab Research Foundation Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
JP5154557B2 (ja) 2006-09-21 2013-02-27 ネステク ソシエテ アノニム 希少循環細胞における多様なシグナル伝達物質検出のための抗体に基づくアレイ
ES2526211T3 (es) 2007-07-13 2015-01-08 Nestec S.A. Selección de fármacos para la terapia del cáncer de pulmón utilizando matrices basadas en anticuerpos
CN102016581B (zh) 2008-02-25 2014-07-30 雀巢产品技术援助有限公司 用抗体阵列选择乳腺癌治疗药物
CN107041948A (zh) * 2009-01-21 2017-08-15 北京三有利科技发展有限公司 细胞生长因子治疗溃疡性疾病和肺纤维化疾病的应用
WO2010132723A1 (fr) 2009-05-14 2010-11-18 Prometheus Laboratories Inc. Biomarqueurs permettant de déterminer la sensibilité de cellules cancéreuses du sein à un traitement ciblant le récepteur her2
JP5795311B2 (ja) 2009-07-15 2015-10-14 ネステク ソシエテ アノニム 抗体ベースのアレイを使用する胃癌療法のための薬物選択
KR20120110168A (ko) 2009-10-20 2012-10-09 프로메테우스 레버러터리스 인코포레이티드 종양원성 융합 단백질을 검출하기 위한 근접-매개 검정법
NZ599456A (en) 2009-10-26 2014-06-27 Nestec Sa Assays for the detection of anti-tnf drugs and autoantibodies
BR112012012513A2 (pt) * 2009-11-25 2017-01-10 Prometheus Lab Inc método para diagnosticar síndrome do intestino irritável em um paciente, método para monitorar a progressão ou regressão da síndrome do intestino irritável em um paciente, e para designar uma terapia contra síndrome do intestino irritável a um paciente em necessidade do mesmo
JP2013528389A (ja) * 2010-06-04 2013-07-11 ネステク ソシエテ アノニム 炎症性腸疾患の診断を改善させる方法
SG189391A1 (en) 2010-10-18 2013-05-31 Nestec Sa Methods for determining anti-drug antibody isotypes
MX2013007429A (es) 2010-12-23 2014-01-31 Nestec Sa Seleccion de farmacos para terapia de cancer maligno usando disposiciones a base de anticuerpos.
ES2530175T3 (es) 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
ES2734673T3 (es) 2011-03-02 2019-12-11 Nestle Sa Predicción de la sensibilidad farmacológica de tumores de pulmón basándose en identificaciones moleculares y genéticas
AU2012278802B2 (en) 2011-07-06 2015-11-26 Société des Produits Nestlé S.A. Assays for detecting neutralizing autoantibodies to biologic therapy with TNF alpha
KR101851425B1 (ko) 2011-09-02 2018-04-23 네스텍 소시에테아노님 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링

Also Published As

Publication number Publication date
AU2013326070A1 (en) 2015-04-23
WO2014054013A1 (fr) 2014-04-10
HK1213051A1 (zh) 2016-06-24
ES2771127T3 (es) 2020-07-06
US20150355195A1 (en) 2015-12-10
AU2019204276A1 (en) 2019-07-04
JP2015532425A (ja) 2015-11-09
EP2904405A1 (fr) 2015-08-12
EP3640645A1 (fr) 2020-04-22
EP3217179B9 (fr) 2020-06-10
MX2015004272A (es) 2015-08-14
EP3217179A1 (fr) 2017-09-13
EP2904405B1 (fr) 2017-05-31
MX358730B (es) 2018-09-03
EP3217179B1 (fr) 2020-01-08
CN104838270A (zh) 2015-08-12
ES2638971T3 (es) 2017-10-24
CA2887035A1 (fr) 2014-04-10

Similar Documents

Publication Publication Date Title
GB2518060B (en) Position monitoring system and method
GB2506001B (en) Structure monitoring
EP2906697A4 (fr) Procédés permettant de surveiller l'expression de c9orf72
GB201214976D0 (en) Monitoring system
EP2911438A4 (fr) Procédé et dispositif de surveillance
EP2913601A4 (fr) Système de contrôle
EP2876622A4 (fr) Dispositif de contrôle d'environnement de véhicule et système de contrôle d'environnement de véhicule
EP2775918A4 (fr) Dispositif et procédés de contrôle de substance à analyser
GB201215649D0 (en) System monitoring
EP2936952A4 (fr) Unité et procédé de refroidissement
HK1213051A1 (zh) 用於預測和監測粘膜愈合的方法
PL2817815T3 (pl) System monitorowania wilgolności
EP2834796A4 (fr) Système de surveillance
EP2699175A4 (fr) Dispositifs de surveillance d'analyte et procédés
EP2900833A4 (fr) Surveillance en temps réel
EP2937807A4 (fr) Dispositif de surveillance et procédé de surveillance
HUP1100486A2 (en) Monitoring system and method
AP3892A (en) Method and device for continuous dry methanisation
EP2929517A4 (fr) Système et procédé de contrôle
EP2801081A4 (fr) Surveillance d'un objet
SI2828926T1 (sl) Nadzorni svetilnik
GB2496402B (en) Monitoring apparatus
GB201204789D0 (en) System monitoring
EP2814393A4 (fr) Compositions et procédés pour la surveillance d'indicateurs biométriques
GB2500000B (en) Microwave monitoring